These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury. Howard ZM; Gomatam CK; Piepho AB; Rafael-Fortney JA Front Pharmacol; 2022; 13():942660. PubMed ID: 35837290 [TBL] [Abstract][Full Text] [Related]
5. Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy. Chadwick JA; Swager SA; Lowe J; Welc SS; Tidball JG; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA Hum Mol Genet; 2016 Dec; 25(23):5167-5177. PubMed ID: 27798095 [TBL] [Abstract][Full Text] [Related]
6. Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle. Chadwick JA; Hauck JS; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA Physiol Genomics; 2017 Jun; 49(6):277-286. PubMed ID: 28432191 [TBL] [Abstract][Full Text] [Related]
7. Cell-type specific effects of mineralocorticoid receptor gene expression suggest intercellular communication regulating fibrosis in skeletal muscle disease. Gomatam CK; Ingale P; Rodriguez G; Munger S; Pomeranets R; Krishna S; Lowe J; Howard ZM; Rafael-Fortney JA Front Physiol; 2024; 15():1322729. PubMed ID: 38737833 [No Abstract] [Full Text] [Related]
8. Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target. Chadwick JA; Hauck JS; Lowe J; Shaw JJ; Guttridge DC; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA FASEB J; 2015 Nov; 29(11):4544-54. PubMed ID: 26178166 [TBL] [Abstract][Full Text] [Related]
9. Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice. Lowe J; Floyd KT; Rastogi N; Schultz EJ; Chadwick JA; Swager SA; Zins JG; Kadakia FK; Smart S; Gomez-Sanchez EP; Gomez-Sanchez CE; Raman SV; Janssen PM; Rafael-Fortney JA J Neuromuscul Dis; 2016; 3(3):395-404. PubMed ID: 27822449 [TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles. Chadwick JA; Bhattacharya S; Lowe J; Weisleder N; Rafael-Fortney JA Am J Physiol Cell Physiol; 2017 Feb; 312(2):C155-C168. PubMed ID: 27881412 [TBL] [Abstract][Full Text] [Related]
11. Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors. Pruthi D; McCurley A; Aronovitz M; Galayda C; Karumanchi SA; Jaffe IZ Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):355-64. PubMed ID: 24311380 [TBL] [Abstract][Full Text] [Related]